Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's disease
- PMID: 10086783
- DOI: 10.1046/j.1365-2141.1999.01208.x
Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's disease
Abstract
To evaluate the possible involvement of vascular endothelial growth factor (VEGF) in the pathogenesis of Castleman's disease, we studied VEGF levels in sera and supernatants of cultured lymph nodes from two patients with the plasma cell type of Castleman's disease, and analysed the expression of VEGF immunohistochemically in the lymph nodes. Clinically, one patient was classified as the localized type and the other as the multicentric type. Histologically, mature plasma cells and hyalinized vessels were prominent in the interfollicular region. The VEGF levels of the sera and the supernatants of cultured lymph nodes of both patients were higher than those of normal controls. VEGF was strongly expressed in plasma cells in the interfollicular region of the lymph nodes of both patients, but rarely in normal lymph nodes. Our results suggest that VEGF may be involved in the marked vascular proliferation in the interfollicular region of the lymph nodes of the plasma cell type of Castleman's disease.
Similar articles
-
Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.Leuk Lymphoma. 2000 Jul;38(3-4):387-94. doi: 10.3109/10428190009087030. Leuk Lymphoma. 2000. PMID: 10830746 Review.
-
Expression of vascular endothelial growth factor in lymphomas and Castleman's disease.J Pathol. 1997 Sep;183(1):44-50. doi: 10.1002/(SICI)1096-9896(199709)183:1<44::AID-PATH1103>3.0.CO;2-I. J Pathol. 1997. PMID: 9370946
-
Multicentric Castleman's disease associated with glomerular microangiopathy and MPGN-like lesion: does vascular endothelial cell-derived growth factor play causative or protective roles in renal injury?Am J Kidney Dis. 2004 Jan;43(1):E3-9. doi: 10.1053/j.ajkd.2003.09.023. Am J Kidney Dis. 2004. PMID: 14712466
-
Secretion of interleukin-6 and vascular endothelial growth factor by spindle cell sarcoma complicating Castleman's disease (so-called 'vascular neoplasia').J Pathol. 2002 Jun;197(2):264-71. doi: 10.1002/path.1110. J Pathol. 2002. PMID: 12015752
-
Castleman's disease.Adv Clin Path. 1999 Jan-Apr;3(1-2):11-22. Adv Clin Path. 1999. PMID: 10655569 Review.
Cited by
-
Pelvic Castleman's disease presenting as an adnexal tumor in a young woman.Obstet Gynecol Sci. 2015 Jul;58(4):323-6. doi: 10.5468/ogs.2015.58.4.323. Epub 2015 Jul 16. Obstet Gynecol Sci. 2015. PMID: 26217605 Free PMC article.
-
Castleman's disease associated with a cerebellar chordoid meningioma and intestinal lymphangiectasia.Childs Nerv Syst. 2010 Nov;26(11):1647-52. doi: 10.1007/s00381-010-1196-9. Epub 2010 Jun 22. Childs Nerv Syst. 2010. PMID: 20567835
-
Does Kaposi's sarcoma predict multicentric Castleman disease in the presence of generalized lymphadenopathy?Med Oncol. 2012 Jun;29(2):1109-13. doi: 10.1007/s12032-011-9886-z. Epub 2011 Apr 7. Med Oncol. 2012. PMID: 21472488
-
Regulation of lymph node vascular growth by dendritic cells.J Exp Med. 2006 Aug 7;203(8):1903-13. doi: 10.1084/jem.20052272. Epub 2006 Jul 10. J Exp Med. 2006. PMID: 16831898 Free PMC article.
-
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome.Eur J Haematol. 2008 May;80(5):397-406. doi: 10.1111/j.1600-0609.2008.01037.x. Epub 2008 Jan 23. Eur J Haematol. 2008. PMID: 18221391 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources